Caspase-8 inactivation drives autophagy-dependent inflammasome activation in myeloid cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36367942.
- Also identified by DOI 10.1126/sciadv.abn9912 and PMC identifier 9651862.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Caspase-8 activity controls the switch from cell death to pyroptosis when apoptosis and necroptosis are blocked, yet how caspase-8 inactivation induces inflammasome assembly remains unclear. We show that caspase-8 inhibition via IETD treatment in Toll-like receptor (TLR)-primed <i>Fadd</i><sup>-/-</sup><i>Ripk3</i><sup>-/-</sup> myeloid cells promoted interleukin-1β (IL-1β) and IL-18 production through inflammasome activation. Caspase-8, caspase-1/11, and functional GSDMD, but not NLRP3 or RIPK1 activity, proved essential for IETD-triggered inflammasome activation. Autophagy became prominent in IETD-treated <i>Fadd</i><sup>-/-</sup><i>Ripk3</i><sup>-/-</sup> macrophages, and inhibiting it attenuated IETD-induced cell death and IL-1β/IL-18 production. In contrast, inhibiting GSDMD or autophagy did not prevent IETD-induced septic shock in <i>Fadd</i><sup>-/-</sup><i>Ripk3</i><sup>-/-</sup> mice, implying distinct death processes in other cell types. Cathepsin-B contributes to IETD-mediated inflammasome activation, as its inhibition or down-regulation limited IETD-elicited IL-1β production. Therefore, the autophagy and cathepsin-B axis represents one of the pathways leading to atypical inflammasome activation when apoptosis and necroptosis are suppressed and capase-8 is inhibited in myeloid cells.
Medical subject headings
- Inflammasomes
- Interleukin-18